Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
259 Cards in this Set
- Front
- Back
What is the life expectancy in diabetic with ESRD
|
3-4 years
|
|
How is risk of CVD increased in Diabetics
|
2-6 times
|
|
What is the overall reduced life expectancy in diabetics
|
7-10 years reduction
|
|
According to DCCT trial, which microvascular complications has greatest reduction following intensive control
|
Retinopathy has greatest impact
Followed by neuropathy and then nephropathy |
|
Which type of cells in generally are affected by chronic hyperglycemia
|
Cells that have intracellular hyperglycemia are affected like Endothelial cells
These are cells which cannot downregulate glucose transport when exposed to extracellular hyperglycemia |
|
What are the consequence of Endothelial cell dysfunction in Diabetics
|
…
|
|
Why is there increase GFR in early Diabetic nephropathy
|
This is because of increase vasoconstriction of efferent arteriole
This is because of 2 reason o Endothelial cell dysfunction- leading to less NO o Increased sensitivity to Angiotensin II |
|
Narrowing of Blood vessels is common pathophysiological process affecting Diabetic microvascular disease. TRUE OR FALSE
|
True
|
|
How does the narrowing of blood vessel take place
|
…
|
|
Which cells are destroyed in Diabetic Retinopathy
|
Pericytes
Endothelial cells Muller cells Ganglion cells |
|
What is Hyperglycemic memory
|
It is proved that a period of good glucose control reduce the risk of microvascular disease ins the subsequent periods of bad glycemic control and vice versa
|
|
Is there a genetic effect of susceptibility to microvascular complications
|
Yes
PATHOPHYSIOLOGY OF MACROVASCULAR DISEASE |
|
What are the special features of Diabetes and Macrovascular disease
|
More Multivessal disease
More rapidly progressive disease More number of diseased segments involved |
|
Does insulin resistance itself confer a cardiovascular risk
|
Yes. Even in Non Diabetic subjects
|
|
What is the characteristic Lipid profile pattern in Diabetic dyslipidemia
|
High amount of Small dense LDL
Low HDL High VLDL High TG |
|
What are the two Pro atherogenic effects of Insulin
|
1. Increased PDGF- Increased Vascular smooth muscles
2. Increase vascular smooth muscle induced PAI- Platlet activator inhibitor (PAI-1) There is selective insulin resistance in Arterial walls which enhance these effects of Insulin Interestingly Hyperglycemia also produces the same effect !! |
|
What is the anti-atherogenic effect of insulin
|
Reduce production of Nitric Oxide
|
|
What is the Proatherogenic effect of Hyperglycemia
|
Reduces Nitric oxide
Pearl Insulin and Hyperglycemia- Increase PDGF derived VSMC and PAI-1 Insulin- Increases NO Hyperglycemia- Reduced NO |
|
What are the two mechanisms of repair of blood supply in the body in case of ischemia
|
Generation of collateral blood flow
Regeneration of blood vessels |
|
Which factor helps in regeneration of blood vessels
|
Circulating endothelial progeniator cells released by bone marrow
|
|
What happens to this progenitor in Diabetics
|
These cells are depleted in Diabetics
|
|
Which factor is critical response to acute ischemia which is depleted in diabetics
|
Hypoxia Inducible factor 1 alpha (HIF-1alpha)
This increases VEGF |
|
Patients with Diabetes have reduced new vessel formation, yet they have Neovascularization in Retina ..why
|
It is a difficult to explain Paradox
Infact the bone marrow derived endothelial progenitor only takes part in the neovascularization in the Retina This is probably because retinal cells donot accumulate blood sugar and hence dono hae reduction of HIF 1alpha HYPERGLYCEMIA INDUCED DAMAGE |
|
Which are the 4 pathways which cause Hyperglycemia induced damage
|
1. Polyol Flux pathway
2. Hexosamine flux pathway 3. Increase protein Kinase C 4. Advanced glycosylated end product |
|
What is the end product of Polyol Flux pathway
|
Sorbitol
|
|
Is Sorbitol really responsible for the complications through Polyol flux pathway
|
Probably not
|
|
So what is really responsible for damage in Polyol flux pathway
|
Increase Polyol flux pathway reduced NADPH
NADPH is required for Glutathione reactivation Absence of glutathione increase oxidative stress |
|
Which is the enzyme involved in the Polyol flux pathway
|
Aldose reductase which has low affinity for glucose
So in normal person this pathway is not active In Hyperglycemia this pathway is active |
|
Which is Aldose reductase inhibitor used in clinical practice
|
Zenarestat (ZEN-A-RESTART)
|
|
Which microvascular complication is most greatly impacted by Zenarestat
|
It benefits Diabetic neuropathy the most
Less effect on Retinopathy and Nephropathy |
|
Why was trial of Zenarestat discontinued
|
Because it had higher dose dependent Renal toxicity
|
|
What are names of Rat models used in Obesity and Diabetes
|
Zucker Rats
|
|
What is the earliest morphological change in Diabetic retinopathy
|
Loss of Pericytes
|
|
Which are the 3 AGE precursors
|
1. Glyoxal
2. Methylglycoxal 3. 3 Deoxyglucasone |
|
Increase of which factor is associated with increase vascular permiablity in diabetics
|
VEGF
|
|
What is the mechanism of Hexosamine flux pathway
|
…
|
|
What is the rate limiting enzyme in Hexosamine pathway
|
GFAT- Glucosamine- Fructose 6 phosphate aminodatransferase
|
|
How is protein Kinase C increased in Diabetics
|
This is because of increase of intracellular second messenger DAG
|
|
Which forms of Protein kinase C are increased in Diabetics
|
Protein Kinase C beta and Delta
|
|
Which is the common pathophysiological process linking the above four theories of Glycemic damage
|
Production of Superoxide by mitochondria electron transport change
|
|
What produces AGE products- intracellular hyperglycemia or extracellular
|
Intracellular hyperglycemia
|
|
what is importance of RAGE in Diabetes therapeutics
|
Receptor of AGE – if inhibited reduced Atherosclerosis in Diabetes prone type 1 Diabetics
RETINOPATHY |
|
What is the most common cause of new onset blindness in Developed countries
|
Diabetic neuropathy
|
|
How do you prevent Diabetic retinopathy
|
There is no current means of preventing Retinopathy
|
|
Which Antihypertensive is known to prevent Diabetic retinopathy
|
ACE and ARB are known to prevent Diabetic retinopathy
|
|
Which 3 agents are used / undergoing trial for treatment of DR
|
PKC-beta
VEGF inhibitor Corticosteroids |
|
What is the 3 earliest pathological change in Diabetic Retinopathy
|
Loss of Retinal pericytes, change in retinal vascularity and thickening of basement membrane
|
|
What produces microaneurysm
|
Loss of retinal pericytes
This results in outpouching of retinal blood vessels Which produces microaneurysm |
|
Which 2 fundus changes are not distinguishable from each other
|
Microaneurysm and Small hemorrhages look similar . Hence they are linked together
|
|
What produces retinal edema
|
Loss of blood retinal barrier produces leakage of fluid which produces edema
|
|
What is the consequence Anterior segment neovascularization
|
Anterior segment neovascularization leads to increase risk of Glaucoma
|
|
By what percentage does Intensive insulin therapy reduce the risk of Diabetic retinopathy
|
Intensive insulin therapy reduces the risk of Diabetic retinopathy by 27%
|
|
Where do flame shaped and where do dot and blot hemorrhages appear
|
Flame shaped hemorrhage are located in Inner retina close to vitreous
Dot and Blot hemorrhages occur in Deeper retina |
|
Where do Cotton wool spots appears
|
Cotton wool spots appear because of Nerve layer infracts
|
|
What do Venous beading and venous caliber changes suggest
|
Venous caliber changes suggests severe retinal hypoxia
|
|
What is ‘Featureless retina’
|
Featureless retina is when retina is extensive vascular loss but Retina is free of proliferative changes
Such retina is suggestive of extensive retinal hypoxia |
|
Which are 3 causes of vision loss in Diabetic retinopathy
|
1. Diabetic macular edema
2. Persistent vitreous hemorrhage 3. Traction retinal detachment |
|
Which is THE most common cause of vision loss in Diabetics
|
Macular edema
|
|
Is Macular edema more common in type 1 or type 2 diabetics
|
Macular edema is more common in type 2 Diabetics
|
|
Are terms like Preproliferative and Background retinopathy still used
|
No
These terms have been replaced |
|
Diabetic macular edema falls in which group Non proliferative or proliferative
|
It falls in either categories
|
|
What is the importance or DRS study
|
It was the first multicentre trial that evaluated use of Panretinal photocoagulation in preventing vision loss in Diabetic retinopathy
|
|
What is ‘Neovascularization at Disc’ and what is ‘Neovascularization elsewhere’
|
Neovascularization at disc refers to Neovascularization within 1500 um of the optic disc
Neovascularization elsewhere refers to Neovascularization beyond 1500 um of the optic disc |
|
Venous caliber abnormalities point to milder grades of NPDR or more severe grade of NPDR
|
It refers to severe grades of NPDR
|
|
What is criteria for Clinically significant macular edema
|
CSME refers to
o Hard exudates within 500 um of fovea o Retinal thickening within 500 um of fovea o Retinal thickening >1500 um within 500 um of Fovea |
|
How does International classification of Diabetic retinopathy classify DR
|
Mild , Moderate and severe NPDR
PDR |
|
What is Mild NPDR
|
Microaneurysms only
|
|
What is Moderate NPDR
|
Between mild and severe NPDR
|
|
What is severe NPDR
|
4-2-1 Rule
> 20 Hemorrhage in all 4 quadrants Venous beading in 2 or more quadrant IRMA in 1 or more qudranat ----- |
|
Can CSME occur with normal vision
|
Yes
|
|
What is the test required for diagnosis of CSME
|
Flouroscein angiography
|
|
How is Diabetes macular edema classified
|
Mild- Retinal thickening/hard exudate near posterior pole, far from centre
Moderate- Retinal thickening approaching the centre but not involving the centre Severe- retinal thickening involving the centre |
|
Which cranial nerves are associated with Diabetes
|
Mononeuropathy of 3,4,6 may be associated with Diabetes
|
|
Amongst these CN, which is least commonly involved
|
CN 4 is least commonly involved
Pearl: Isolated mononeuropathy of 3,4,6 cranial nerves should prompt the search for Diabetes |
|
What are the causes of Optic disc pallor in Diabetes
|
May occur after spontaneous remission of PDR or remission after laser photocoagulation
|
|
Is Open angle glaucoma more common in Diabetics
|
Yes
It is 1.4 times more common |
|
IS Cataract more common in Diabetics
|
Yes
It is 1.6 times more common |
|
What is the reason for fluctuation of vision in Diabetes
|
It is because of osmotic lens swelling
|
|
Which is the dangerous infection of Diabetes which affects the orbit
|
Mucormycosis
|
|
What is the treatment for CSME
|
Focal / Grid laser photocoagulation
|
|
What is the indication for Panretinal photocoagulation
|
1. PDR
2. Severe NPDR |
|
How frequently are DME followed up
|
Every 3 months
|
|
How frequently are Severe NPDR followed up
|
Every 4 months
|
|
How frequently are mild and moderate NPDR followed up
|
Mild- every 8-12 months
Moderate- every 4-8 months Severe- every 4 months Summary of follow up No DR- Every 12 month Mild NPDR- every 8-12 months Moderate NPDR- every 4-8 months Severe NPDR- every 4 months DME- every 3 months |
|
How frequently are pregnant patients with DR followed up
|
In each trimester – every 3 months
|
|
Which 2 conditions accelerate retinopathy
|
Puberty and pregnancy
|
|
What is the treatment of cases of Proliferative retinopathy which cannot be treated with Photocoagulation
|
Pars plana vitrectomy must be done
|
|
What is the method of choice for Diagnosing CSME
|
OCT- optical coherence tomography
|
|
What is the role of Floroscein angiography in CSME
|
Floroscein angiography is used once the diagnosis of CSME is established
It is used for identifying lesions which which are close to macula which are contributing to macular thickening These lesions are identified and photocoagulated |
|
Is there an effect of Pan retinal scatter photocoagulation on macular edema
|
Yes, Pan retinal Scatter photocoagulation worsens macular edema
|
|
Why should patients with severe NPDR undergo focal photocoagulation even if they don’t have macular edema
|
Because they may require scatter photocoagulation in future which can worsens macular edema
So at present they are to undergo panretinal photocoagulation |
|
Which is the novel therapy developed in treatment of Diabetic retinopathy
|
Intraviterous injection of Anti- VEGF inhibitors are newer drugs developed in treatment of diabetic retinopathy
|
|
Which are the new anti VEGF inhibitors
|
Bevacizumab
Ranibizumab |
|
Which other agent is used in treatment of DME
|
Intraviteral injection of corticosteroids is used in treatment of DME
Steroids help in reduction of Retinal thickning |
|
What are the side effects of these steroid injections
|
Increase of intraocular pressure and increase risk of cataract
|
|
What % of patients with Type 2 Diabetes are also hypertensive
|
38-58% of patients with type 2 Diabetes are also hypertensive
|
|
What is the effect of concomitant hypertension on DR
|
More severe grades of Retinopathy and more rapid progression of retinopathy
|
|
A patient has rapidly progressive retinopathy , apart from Hypertension what else should be considered
|
The renal status of the patient should be considered
|
|
What is the relation of Hemoglobin with Retinopathy
|
Low Hematocrit is associated with increased risk of progression of retinopathy
Hence anemia in diabetics should be treated |
|
What kind of hypogonadism is associated with Obesity – Hypo Hypo or Hyper hypo
|
Hypo Hypo
DIABETIC NEPHROPATHY |
|
Nephropathy is more common in type 1 or type 2 Diabetes
|
It is more common in type 1
However because of more number of Type 2- more patients of type 2 come in picture |
|
What is the classical triad of Diabetic nephropathy
|
Hypertension
Proteinuria Renal impairment |
|
Who described the 5 stages of Diabetic nephropathy
|
Mogensen
|
|
Which are the 5 stages of Diabetic nephropathy
|
Hyperfiltration
Silent Microalbuminuria Macroalbuminuria Renal impairment |
|
What is the cause of Hyperfilteration in the stage I of DN
|
Because of concomitant renal hypertrophy
|
|
Is there glomerular or tubular hypertrophy in DN
|
Both
|
|
Which factors are responsible for the hypertrophy
|
GH
TGF beta |
|
What are the structural changes seen in the silent phase of DN
|
Mesangial expansion
Basement membrane thickening |
|
Are there any markers that can identify the silent phase of the disease
|
None have been validated
Some approaches include o Measurement of Albumin fragments (Ghost fragments) in urine o Prorenin o ACE genotype o Modest raise in BP seen on ABPM |
|
Define microalbuminuria in ug/min
|
20-200 ug/min
|
|
When is the Urine albumin/creat sample taken
|
Early morning Spot sample
|
|
Is regression of microalbuminuria possible
|
Yes
One study showered regression in 58% of patients |
|
How frequently should urine albumin/creat ratio be done in Type 1 Diabetics
|
Williams recommends twice annually !!
|
|
Is Pancreas-kidney transplant better than Kidney transplant alone
|
Yes
Pancreas-kidney transplant is better than kidney transplant alone |
|
Does hyperfilteration occur in Type 2 Diabetes
|
Yes
Hyperfilteration also occurs in type 2 Diabetes but it is less common than Type 1 Diabetes |
|
Is microalbuminuria specific for DN in type 2 Diabetes
|
No
There are other cause of Microalbuminuria as well in type 2 DM which include o UTI o Cardiac failure o Enlarged prostrate |
|
Can patients with Diabetes develop Renal impairment without proteinuria
|
Yes
PATHOGENESIS OF DIABETIC NEPHROPATHY |
|
Which factor plays a central role in Diabetic nephropathy
|
Mitochondrial ROS plays a central role on Diabetic nephropathy
PATHOLOGY |
|
What factor contributes to the Proteinuria in DN
|
Podocyte dysfunction and apoptosis contributes to the proteinuria in DN
|
|
Are just the glomerular changes in Diabetes important
|
No
Recent studies have shown significant changes in the renal tubules as well It is called Diabetic Tubulopathy Pearl: Loss of the Tubuloglomerular feedback drives the hyperfilteration seen in early phases of Diabetic nephropathy |
|
Renal function detoriation has more to do with Glomerular or tubular dysfunction in DN
|
It has more to do with Tubular rather than glomerular dysfunction \
|
|
Do patients with Diabetes have increase risk of Renal artery stenosis
|
Yes
Many are angiographically non significant However, if significant can lead to increase risk of Acute pulmonary edema |
|
What type of RTA is common in diabetics
|
Type IV RTA
This increases risk of Severe hyperkalemia |
|
What is Benfothiamine and what is its role
|
Benfothiamine is a derivative of thiamine that reduces the reactive oxygen species
|
|
Which is more important for reducing microalbuminuria – Blood pressure or blood sugar
|
Blood pressure
|
|
Which serum marker is a identifies patients who are normalalbuminuric having increased risk of Diabetic nephropathy
|
Serum prorenin
|
|
Which is the drug of choice for BP reduction in Type 2 Diabetics with Albuminuria
|
ARB
|
|
Which studies showed these benefits of ARB
|
RENAAL – which invoved Losartan
IDNT- Which involved Irbesartan |
|
Is there any difference in use of ACEI vs ARB
|
No
|
|
Which other drugs have been found to have additive renoprotective effect
|
Alsikiren
Eprelenone |
|
Is there any benefit of Low protein diet
|
Low protein diet 0.75 gram/kg found to have modest benefit in patients with DN
|
|
Which lipid lowering drug is found to reduce progression of Diabetic nephropathy
|
Fenofibrate
|
|
is there any advantage of using EPO in patients with DN
|
Role of EPO as renoprotective effect is controversial
Q . Which drug is PKC beta inhibitor ? Ruboxistaurin But It has failed to show any benefit in patients with DN |
|
Which other drugs are tried in DN
|
Sulodexide (SULO- DESK – SITE)
Avosentan- endothelial receptor antagonist (AVO- SENTAN –A ) DIABETIC NEUROPATHY Pearl: Diabetic neuropathy can also in Impaired glucose tolerance as well as Metabolic syndrome without Overt Diabetes It is the most common neuropathy worldwide |
|
Classify diabetic neuropathy based on San Antonio classification
|
Subclincial neuropathy
Diffuse clinical neuropathy o DSPN o Autonomic neuropathy Focal syndromes |
|
Which new diagnostic technique has become popular for diagnosis of Diabetic DSPN
|
Skin biopsy
|
|
What is the advantage of skin biopsy
|
It can diagnose small fibre neuropathy even If the NCV has still not picked up the neuropathy
|
|
Which marker is used for diagnosis of DSPN
|
PSP 9.5 – Panaxonal marker protein gene product 9.5 is used for diagnosis of DSPN
|
|
What is the key measurement on nerve biopsy
|
Intraepidermal nerve fibre density is the key measurement
|
|
Which loss is more prominent in NCV in patient with Diabetic neuropathy- Axonal or demyelinating
|
Axonal
Hence amplitude is reduced |
|
Are changes in NCV more appropriate way of follow up of patients with DN
|
No
Changes in NCV are not a good way of following up a patient Change in NCV may not correlate with severity |
|
What is the importance of Autonomic neuropathy on mortality
|
Autonomic neuropathy is associated with increase risk of Cardiovasular mortality and MI
|
|
Define Diabetic neuropathy
|
the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes
|
|
Absence of symptoms means absence of neuropathy- True or false
|
False
Often neuropathy may be asymptomatic |
|
What is the minimum thing required for diagnosis of Diabetic neuropathy
|
Atleast 2 signs and symptoms are required for diagnosis of Diabetic neuropathy
|
|
Mononeuropathy are common in what profile of diabetics
|
In older diabetics
|
|
What is the cause of mononeuropathy
|
It is often due to vascular cause
|
|
what is the onset and course of neuropathy
|
Hence often presents acutely and self resolves in 6-8 weeks
|
|
What is the main difference between Diabetic mononeuropathy and entrapment neuropathy
|
Diabetic mononeuropathy is acute while entrapment neuropathy is slow and progressive
|
|
Which common nerves are involved in Diabetic Mononeuritis
|
C3, C6, C7, median , ulnar , peroneal
|
|
Is carpal tunnel more common in diabetics
|
Yes
It is 3 times as common in diabetics as general population 1/3rd diabetics have it ! |
|
What is the surgical treatment of CTS
|
Sectioning of volar carpal ligament is the surgical treatment of CTS
DIFFUSE NEUROPATHIES PROXIMAL MOTOR NEUROPATHIES (DIABETIC AMYOTROPHY) |
|
Describe the clinical presentation of Diabetic amyotrophy
|
Begins in elderly
Start unilaterally as pain in the thighs or hips followed by buttocks This is followed by significant pain in the proximal limbs followed by weakness Associated with DSPN and Muscle fasciculation Later may spread bilaterally |
|
Is diabetic amyotrophy due to Diabetes
|
No
It is now recognized that its cause is something else However it is more common in Diabetics |
|
Which muscles are involved in Diabetic amyotrophy
|
Iliopsoas
Obutrator Adductor |
|
Which muscles are spared in Diabetic amyotrophy
|
Gluteus maximums , minimus and hamstrings
|
|
What does NCV show in such a patient
|
Axonal loss
Picture like Lumbosacaral plexopathy |
|
A patient has similar picture but NCV shows demyelination, what is the diagnosis
|
Than its more likely CIDP or MGUS or vasculitis rather than Diabetic amyotrophy
|
|
Is CIDP also more common in diabetics
|
Yes
Sharma et al found that CIDP is more common in Diabetics |
|
Why is differentiation between CIDP and Diabetic amyotrophy important
|
Because treatment is different
CIDP responds well to IVIG while DA runs a progressive course |
|
What are the clinical features of Spinal stenosis
|
Claudciation and pain on walking downhill
Relived by bending forward DISTAL SYMMETRICAL POLYNEUROPATHY |
|
Can DSPN have an acute onset
|
Yes
It could often be because of stress or treatment of hyperglycemia Pearl: Treatment of Diabetes may often precipitate symptoms of DSPN |
|
Is DSPN sensory or motor
|
It can be both sensory and motor
Can involve both large or small fibres |
|
What are techniques for evaluating small fibre neuropathy
|
Skin biopsy with staining for neuronal antigen PGP 9.5 – Method of choice
Others are o Corneal confocal microscopy o Laser doppler flare reaction to cholinergic stimulation o Sudomotor responses to cholingergic stimulation -------------- PAIN IN DIABETIC NEUROPATHY ACUTE PAINFUL NEUROPATHY |
|
What is Insulin neuritis
|
Acute (<6 months)
Painful Small fibre neuropathy On starting of Insulin or SU Pain is more in night More in the feet |
|
What is Diabetic Neuropathic cachexia
|
Another painful small fibre neuropathy
Associated with weight loss and depression More in males Responds to Symptomatic treatment CHRONIC PAINFUL NEUROPATHY |
|
What are features of chronic painful neuropathy
|
Lasts for > 6months
Patient develops tolerance to even narcotics Difficult to treat |
|
Is loss of pain always a good sign
|
Not necessarily
Loss of pain may sometimes herald progression of neuropathy |
|
What is difference between Hyperalgesia and Allodynia
|
Hyperalgesia is increased pain on painful stimulus
Allodynia is increased pain on stimulus that is generally not painful |
|
Which fibres produce Hyperalgesia
|
A – Delta and C fibres
|
|
Which fibres produce allodynia
|
A beta
SMALL FIBRE NEUROPATHY |
|
Which fibre produces pain in Small fibre neuropathy
|
C fibres
|
|
How is clinical diagnosis of small fibre neuropathy done
|
Using 1.0 gram Semmes- Weinstein filament
Or use of Wartenberg wheel Figure 1 WARTENBERG WHEEL |
|
What are NCV changes in small fibre neuropathy
|
Normal
|
|
How is diagnosis of Small fibre neuropathy confirmed
|
Loss of cutenous nerve fibre that stain for PGP 9.5 on skin biopsy
|
|
What happens to reflexes and motor in Small fibre neuropathy
|
They are normal
LARGE FIBRE NEUROPATHY “Neuropathy of signs rather than symptoms” |
|
Which are effect first – small fibre or large fibres
|
Large because they are longer
|
|
Where to large fibres synapse
|
In medulla
|
|
Which sensation are controlled by large fibres
|
Vibration
Position Cold thermal sensation |
|
What are symptoms of large fibre neuropathy
|
Sensation of walking on wool
CLINICAL PRESENTATION |
|
Which is the first symptom of large fibre neuropathy
|
Loss of vibration sensation
|
|
What are the signs or large fibre neuropathy
|
Sensory
Loss of vibration Loss of Tendon reflex Sensory ataxia Loss of position sense Motor Waddling gait Wasting of small muscles of foot Hammer toes Pes equinus Figure 2 PES EQUINUS Autonomic Hot foot- increase vascularity of feet |
|
Which is sign of severe neuropathy
|
Inabilty to stand on toes or feet – sign of severe neuropathy
Diagnosis and Differential Diagnosis of Peripheral Neuropathy |
|
Name 3 questionnares developed for diabetic neuropathy
|
Vinik
Dyke Young |
|
What frequency of tuning fork must you use for diagnosis of Diabetic neuropathy
|
Tuning fork of 128 Hz
|
|
Can you use other tuning fork
|
No
|
|
Name the tests for diagnosis of
Small fibre neuropathy Large fibre neuropathy Autonomic neuropathy of foot |
Answer
Small fibre neuropathy – Skin biopsy and loss of PGP 9.5 staining nerve fibres Large fibre neuropathy - NCV / EMG Autonomic neuropathy of foot - QAFT- quantitative autonomic function test |
|
Which is good clinical test for Entrapment neuropathy
|
Tinel’s sign
|
|
Which is the questionnaire useful for screening patients with Diabetic neuropathy
|
Michigan neuropathy screening instrument
|
|
What is the name of the severity grading used for diabetic neuropathy
|
Dyck staging
|
|
Describe the Dyck staging
|
N0- Ne neuropathy
N1a- No signs or symptoms- but abnormalities on Testing N1b- No symptoms but neuropathy signs present N2a - Signs and symptoms present N2b- Above plus ankle dorsiflexor weakness N3- severe diabling neuropathy |
|
Is QST useful for routine use
|
AAN recommends QST mainly for clinical trials and does not recommend it for routine use
Peripheral Testing Devices |
|
What does Semmes Weinstein filament test
|
It tests pressure sensation
|
|
How much pressure is applied
|
Enough pressure is applied to buckle the Filament
|
|
Which monofilament is most commonly used in clinical practice
|
10 g monofilament
|
|
What is the 10 g monofilament called in clinical practice
|
5.07 filament
|
|
Why is it called 5.07 filament
|
The filaments are calibrated to exert a force that is 10 times the log of force applied on tip
Hence 5.07 applies 10 g force on tip |
|
How many sites on foot must be tested by monofilament
|
There is no concensus
But generally 4 sites are tested |
|
Which are these 4 sites
|
Hallux
1st , 3rd and 5th metatarsal heads |
|
What does monofilament testing actually predict
|
It predicts the future risk of developing foot ulcers
|
|
Which monofilament is more sensitive and which is more specific
|
1 g monofilament is more sensitive
10 g monofilament is more specific |
|
What is Rydel Seifer tuning fork
|
It has optical illusion to allow assessor to determine intensity of residual vibration on scale of 0 to 8
|
|
What is principle of Corneal confocal microscopy
|
Corenal confocal microscopy helps visualize unmyelinated axons In cornea
These are lost early in Diabetic neuropathy and predict the development of Diabetic neuropathy Figure 3 CONFOCAL MICROSCOPY MANAGEMENT |
|
Diabetes affects- Amplitude or velocity on NCV
|
It mainly affects the amplitude
|
|
Is there benefit of Glycemic control on preventing progession of diabetic neuropathy
|
Yes
|
|
What is the mechanism of action of Aldose reductase inhibitors
|
Aldose reductase inhibitors reduce the flux of flux of glucose to polyol pathway
|
|
Name some Aldose reductase inhibitors
|
Tolrestat
Zenarestat Zopolrestat |
|
How does Alpha Lipoic acid act
|
It’s a cofactor for pyruvate dehydrogenase complex
Its helps in replenishing thiol group and acts as a redox modulating agent Its basically an antioxidant |
|
Which essential fatty acid is used in treatment of diabetic neuropathy
|
Gamma linoleic acid (γ-linolenic acid)
|
|
Name a PKC-Beta inhibitor
|
Ruboxistaurin
------- |
|
When is IVIG used in treatment of diabetic neuropathy
|
It is used when anti-neuronal antibodies are positive
PAIN CONTROL |
|
What is type of Pain in C fibre pain
|
Burining , lacinating pain with parastheesia and hyperalgesias
|
|
Which drug is useful for C fibre pain
|
Clonidine or Capsaicin cream
C fibre pain is because of small unmyelinated fibres There is a cross sensitivity between pain and sympathetic fibres , hence clonidine is useful Clonidine can also be applied locally |
|
How can Capsaicin cream be made at home
|
It can be made my putting 1-3 teaspoons of Ceynne pepper in Cold cream and applying to the affected part
The affected part is then wrapped with Cellophane paper There is initial exacerbation of pain followed by reduction of pain in 2-3 weeks by depletion of substance P in the umyleinated fibres that cause pain |
|
What type of Pain is found because of A-delta fibres
|
It is a more deep seated , gnawing pain
It does not respond to above measures |
|
Which agents are used for A delta pain
|
Continous insulin infusion
o Patient responds within 48 hrs Nerve blocking agents- local or systemic Lidocaine or Mexiletine Opioids like Tramadol Dextrometorphan- NMDA receptor blocker TCA- Amitryptiline and Nortryptiline SSRI Anticonvulsants |
|
What is advantage of Nortryptiline over Amitryptiline
|
It has lesser sedation compared to Amitryptiline
Brand is NOTRI 25 mg HS |
|
Which SSRI is found to be best
|
Paroxetine (PARI- CR 12.5 mg HS )
|
|
What is the dose of Duloxetine used in Diabetic neuropathy
|
60-120 mg
|
|
in which patients Duloxetine must be avoided
|
Must be avoided in patients with Bipolar tendencies , as it increases risk of Sucidal ideation
|
|
What is mechanism of Action of Pregabalin
|
It is GABA analogue
|
|
What is minimum dose useful for Pregabalin
|
It is 150 mg – can go upto 600 mg
|
|
Is phenytoin useful in diabetic neuropathy
|
No
Studies have shown it not be beneficial |
|
What is the major problem with use of Phenytoin in diabetes
|
Phenytoin in Diabetes suppresses insulin secreation and can hence increase the risk of precipitating hyperosmolar diabetic coma
|
|
What is the advantages of Gabapentin over other drugs
|
It is known to improve Mood and improve sleep
|
|
What is the disadvantage of Gabapentin
|
It is not found useful in all trials
Effective Dose required is higher – 1800-3000 mg And associated with weight gain |
|
Can Lamotrigine be used in management of painful neuropathy
|
Yes
|
|
Which anticonvulsant has anti-diabetes properties and is known to help increase the intraepidermal nerve fibre density
|
Topiramate
|
|
What are other benefits of Topiramate use in Diabetes
|
Also reduces blood pressure and has favourable effect on lipids
TOPIRAMATE- NEXTOP- 25 MG AT BEDTIME |
|
Williams recommends which drug as first line in treatment of painful diabetic neuropathy
|
TCA
IMP PARA |
|
Which are some of the newer technologies used in treatment of Neuropathy
|
Trancutenous electric nerve stimulation
Static magnetic field therapy Infrared light |
|
Which other hormone is found to be useful in painful diabetic neuropathy
|
Calcitonin given in dose of 100 IU for 2 weeks often caused complete resolution of painful diabetes neuropathy
PATIENTS WITH LARGE FIBRE NEUROPATHY HAVE HIGHER TENDENCY TO FALL Q . What is the recommended physical thing in Large fibre neuropathy ? Patients should undergo strength training to improve muscle strength in large fibre neuropathy |
|
How do you assess the efficacy of the strength training in diabetic large fibre neuropathy
|
By asking patient to do a backward tandem walking
AUTONOMIC NEUROPATHY |
|
What pupillary abnormality is seen in Diabetic autonomic neuropathy
|
Argyl Robertson pupil
Increased diameter of Dark adapted pupil |
|
Autonomic neuropathy is a late sign of diabetic neuropathy , TRUE OR FALSE
|
False
It can often occur early |
|
What are the effects of Autonomic neuropathy on blood pressure
|
Patient may have paradoxical supine or nocturnal hypertension
|
|
Amongst complications of Diabetes, which is the greatest predictor of Mortality and CV risk
|
Autonomic neuropathy
|
|
Amongst test for autonomic neuropathy, which one should be done definitely
|
Cardiac autonomic testing must be done
Other are not required routinely Also if cardiac autonomic testing is normal, then Autonomic neuropathy can actually be ruled out DIAGNOSTIC TESTS FOR CARDIAC AUTONOMIC NEUROPATHY |
|
What is first thing done for diagnosis of Cardiac autonomic neuropathy
|
Resting heart rate is first checked
HR >100 is abnormal |
|
Describe heart rate change on standing
|
Normally on standing there is initial reflex tachycardia followed by bradycardia
The RR interval at beats 30 and beat 15 are taken Ratio of RR at 30:15 > 1.03 is normal |
|
How to perform the test for Valsalva variability and its interpretation
|
During ECG recording patient is asked to blow in to Sphygmonamometer with pressure at 40 mm Hg
There is initially tachycardia during strain and overshoot bradycardia later The ratio of longest RR to shortest RR >1.2 – which is normal |
|
How is systolic BP during standing done and interpreted
|
BP is taken in supine position
Patient is asked to stand for 2 min Systolic BP is taken again o Fall by <10 mm Hg- normal o 10-30 mm Hg – borderline o >30 mm Hg- abnormal |
|
What is importance of QTc interval for autonomic testing
|
QTc >440 ms suggest autonomic dysfunction
|
|
What is effect of isometric hand grip and Diastolic BP
|
Patient is asked to squeeze handgrip dynamometer for 5 min
The diastolic pressure in other arm raised by >16 mm Hg MANAGEMENT OF AUTONOMIC NEUROPATHY |
|
What dietery advice would you give patient with Diabetic gastropathy
|
Small frequent meals
Less fat in diet |
|
Which antibiotic is used in Diabetic gastroparesis
|
Erythromycin
|
|
How frequent is ED in Diabetic males
|
Present in 50-75%
|
|
What are indirect evidence that ED in diabetes is because of Autonomic dysfunction
|
Loss of Ankle jerks and reduction in Vibration sense over great toe often accompanies ED because of autonomic dysfunction in Diabetics
|
|
What is importance of Penile – Brachial index
|
Penile brachial index <0.7 suggest vascular insufficiency of the penis
|
|
Which investigation would help differentiate psychogenic from organic ED
|
Nocturnal penile tumescence (NPT)
|
|
Name 3 drugs used in treatment of Orthostatic hypotension
|
Fludrocortisone
Octerotide Clonidine |
|
What is the endocrine side effect of Levosulfide
|
Galactorrhea
|
|
What is diabetic Cystopathy
|
Loss of bladder sensation due to diabetes
The bladder are often full and upto umbilicus yet the patient has no bladder sensation It often produces overflow incontinence and increases UTI risk |
|
Which maneuver helps empty the bladder in patients with Cystopathy
|
Crede’s maneuver
|
|
Which drug is used in treatment of Diabetic cystopathy
|
Bethanecol
Parasympethomimetic DRUG: BETHACOL 25 MG TID |
|
What Typical sweating abnormality is seen in Diabetics
|
Gustatory sweating esp. in upper body is very typical
It is treated with topical glycopyrrolate |
|
What happens to sweating in lower body
|
Anhidrosis is more common in lower body
This leads to cracks and fissures in Diabetic foot |
|
What is Hypoglycemic unawareness
|
Lack of Cathecholamine response to neuroglycopenia is known as Hypoglycemic unawareness
|
|
What happens to Glucagon response in Type 1 Diabetics
|
Glucagon response in type 1 Diabetics, reduces after 1-5 years and is almost absent after 15-30 years
CORONARY ARTERY DISEASE Effect of Diabetes on Risk of Coronary Heart Disease Depression of myocardial GLUT4 levels in the setting of diabetes and ischemia inhibits glucose entry and glycolysis in the heart. As a result, intracellular metabolism shifts from glycolysis to FFA oxidation, thereby suppressing glycolytic ATP generation, a major source of energy under anaerobic (i.e., ischemic) conditions.869 The production of oxygen free radicals can also be enhanced in this situation, further depressing myocardial contractile function. The Diabetic Foot (See separate notes) |